Providence Medical Technology Announces Expansion of Patent Portfolio

Three Additional Patents Issued Protecting DTRAX Platform for Cervical Fusion

LAFAYETTE, Calif. — (BUSINESS WIRE) — Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014

“We are proud of our growing patent portfolio protecting our innovative suite of cervical fusion products,” commented Jeff Smith, Chief Executive Officer of Providence Medical Technology. “We believe that our method of accessing the posterior aspect of the cervical spine is unique, and that placement of implants, regardless of design, via this approach is an area of significant differentiation for our product line.”

These new issuances bring the total number of patents issued to Providence to 13.

  •   8,834,530: Cervical Distraction Method describes a method of implanting an implant in a facet joint, including puncturing an access hole in a facet capsule, accessing the facet joint with a guide tool through the access hole, and routing an implant into the joint along the guide tool.
  •   8,834,472: Vertebral Joint Implants and Delivery Tools describes a system for minimally invasively accessing a spinal facet joint space via a posterior approach in preparation for delivering an implant to the spinal facet joint space.
  •   8,828,062: Vertebral Joint Implants and Deli
    very Tools describes a method of implanting a spinal implant in a facet joint.About ProvidenceProvidence Medical Technology is a privately held medical device company developing minimally disruptive solutions addressing the $1 billion worldwide cervical spine market. We are commercializing the DTRAX platform of differentiated cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression and fusion.


Contact Information:

Michael Miller
Director, Marketing
Providence Medical Technology, Inc.

Source: Providence Medical Technology, Inc.

Scroll to top